Advertisement
For the complete version of this earnings report, please visit:www.genommalab.com .3Q08 Highlights (vs. 3Q07) -- Net sales reached Ps. 712.4 million, an increase of 42.9%. -- Gross profit was Ps. 538.2 million, an increase of 45.3%. -- EBITDA(1) increased 40.2% to Ps. 201.8 million. -- Consolidated net income rose 32.4% to Ps. 150.7 million. -- Earnings per share(2) increased 109.8% to Ps. 0.80. -- During the third quarter, we successfully launched eight products under five existing brands (Base Brands(3) and Prior Year Launches(4)) as part of our line extension strategy. -- We also launched four products under two New Brands(5), as part of our new products launch plan during the third quarter.
SOURCE Genomma Lab Internacional
